Latorre, M <br/><br/>
Differences in the efficacy and safety among inhaled corticosteroids (ICS)/long-acting beta2-agonists (LABA) combinations in the treatment of chronic obstructive pulmonary disease (COPD): Role of ICS.  [electronic resource] 

 -  Pulmonary pharmacology & therapeutics  Feb 2015 
 - 44-50 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1522-9629 
<br/><br/><label>Standard No.: </label>10.1016/j.pupt.2014.10.006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Inhalation<br/>Adrenergic beta-2 Receptor Agonists--administration & dosage<br/>Drug Combinations<br/>Glucocorticoids--administration & dosage<br/>Humans<br/>Pulmonary Disease, Chronic Obstructive--drug therapy<br/>Quality of Life